Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Glue

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
Journal of Psychopharmacology (Oxford, England)|September 12, 2024
Response to Letter to the Editor Navigating the challenge of patient selection and scales to measure outcomes in ketamine trials for treatment-resistant depressionPaul Glue, Neil McNaughton,
Human Psychopharmacology|April 7, 2020
Progesterone loading as a strategy for treating postpartum depressionYoram Barak, Paul Glue
The Australian and New Zealand Journal of Psychiatry|November 8, 2015
Comparative efficacy and acceptability of combined antipsychotics and mood stabilizers versus individual drug classes for acute mania: Network meta-analysisPaul Glue, Peter Herbison
Journal of Affective Disorders|December 20, 2017
Dissociation after ketamine dosing: Is the CADSS fit for purpose?Shona Neehoff, Paul Glue
The New England Journal of Medicine|April 27, 2018
Prazosin for Post-Traumatic Stress DisorderPaul Glue, Yoram Barak
Psychedelic Medicine (New Rochelle, N.Y.)|September 11, 2025
Systematic Review of the Effect of Psychedelic-Assisted Therapy on Attitudes Toward Death, Life, and Spirituality on Symptoms of Distress, Depression, and/or Anxiety in Patients with Life-Threatening IllnessThivya Turner, Paul Glue
The New Zealand Medical Journal|March 7, 2013
Do all antidepressants cause QT prolongation--how good is the evidence?Paul Glue, Chris Gale
The New Zealand Medical Journal|February 23, 2018
How comprehensive is suicide risk assessment in the emergency department?Christopher Gale, Paul Glue
Lancet (London, England)|March 13, 2012
Comparative efficacy of anti-manic drugs in acute maniaPaul Glue, Greg Tarr
Journal of Clinical Pharmacology|June 22, 2026
Ketamine Dosing Across Clinical Indications: A Narrative Review Organized by Proposed NMDA-Related MechanismsPaul Glue, Ben Beaglehole
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Journal of Psychopharmacology (Oxford, England)|September 12, 2024
Response to Letter to the Editor Navigating the challenge of patient selection and scales to measure outcomes in ketamine trials for treatment-resistant depressionPaul Glue, Neil McNaughton,
Human Psychopharmacology|April 7, 2020
Progesterone loading as a strategy for treating postpartum depressionYoram Barak, Paul Glue
The Australian and New Zealand Journal of Psychiatry|November 8, 2015
Comparative efficacy and acceptability of combined antipsychotics and mood stabilizers versus individual drug classes for acute mania: Network meta-analysisPaul Glue, Peter Herbison
Journal of Affective Disorders|December 20, 2017
Dissociation after ketamine dosing: Is the CADSS fit for purpose?Shona Neehoff, Paul Glue
The New England Journal of Medicine|April 27, 2018
Prazosin for Post-Traumatic Stress DisorderPaul Glue, Yoram Barak
Psychedelic Medicine (New Rochelle, N.Y.)|September 11, 2025
Systematic Review of the Effect of Psychedelic-Assisted Therapy on Attitudes Toward Death, Life, and Spirituality on Symptoms of Distress, Depression, and/or Anxiety in Patients with Life-Threatening IllnessThivya Turner, Paul Glue
The New Zealand Medical Journal|March 7, 2013
Do all antidepressants cause QT prolongation--how good is the evidence?Paul Glue, Chris Gale
The New Zealand Medical Journal|February 23, 2018
How comprehensive is suicide risk assessment in the emergency department?Christopher Gale, Paul Glue
Lancet (London, England)|March 13, 2012
Comparative efficacy of anti-manic drugs in acute maniaPaul Glue, Greg Tarr
Journal of Clinical Pharmacology|June 22, 2026
Ketamine Dosing Across Clinical Indications: A Narrative Review Organized by Proposed NMDA-Related MechanismsPaul Glue, Ben Beaglehole
Pageof 18